M. Yalçin Mutlu

Palpable purpura: is it associated with vasculitis or not? A single-center experience

C. Beş, Gizem Kaynar Özçelik, O. C. Içaçan, 2022, Clinical Rheumatology.

Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis—A case report and literature review

G. Schett, K. Tascilar, D. Simon, 2022, Frontiers in Medicine.

Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy

A. H. Yardimci, M. Erdogan, C. Beş, 2021, Lupus.

Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus associated refractory cerebral vasculitis induces immune tolerance.

G. Schett, K. Tascilar, D. Simon, 2022, Rheumatology.

Intensity and longevity of SARS-CoV-2 vaccination response and efficacy of adjusted vaccination schedules in patients with immune-mediated inflammatory disease

R. Atreya, A. Liphardt, G. Schett, 2022, medRxiv.

Pulmonary involvement in antineutrophil cytoplasmic antibody‐associated vasculitides: A single center experience from Turkey

C. Beş, O. C. Içaçan, M. Yalçin Mutlu, 2023, International journal of rheumatic diseases.

Efficacy of tocilizumab treatment in COVID-19 patients with cytokine release syndrome

M. Hurşitoğlu, Ş. Karabela, N. Isiksacan, 2021 .